This joint ASGE-ESGE guideline provides an evidence-based summary and recommendations regarding the role of endoscopic bariatric and metabolic therapies (EBMTs) in the management of obesity. The document was developed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework. It evaluates the efficacy and safety of EBMT devices and procedures that currently have CE mark or FDA-clearance/approval, or that had been approved within five years of document development. The guideline suggests the use of EBMTs plus lifestyle modification in patients with a BMI of ≥ 30 kg/m2, or with a BMI of 27.0-29.9 kg/m2 with at least 1 obesity-related comorbidity. Furthermore, it suggests the utilization of intragastric balloons and devices for endoscopic gastric remodeling (EGR) in conjunction with lifestyle modification for this patient population.

American Society for Gastrointestinal Endoscopy-European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity / Jirapinyo, Pichamol; Hadefi, Alia; C Thompson, Christopher; V Patai, Árpád; Pannala, Rahul; K Goelder, Stefan; Kushnir, Vladimir; Barthet, Marc; M Apovian, Caroline; Boskoski, Ivo; G Chapman, Christopher; Davidson, Paul; Donatelli, Gianfranco; Kumbhari, Vivek; Hayee, Bu; Esker, Janelle; Hucl, Tomas; D Pryor, Aurora; Maselli, Roberta; R Schulman, Allison; Pattou, Francois; Zelber-Sagi, Shira; A Bain, Paul; Durieux, Valérie; Triantafyllou, Konstantinos; Thosani, Nirav; Huberty, Vincent; Sullivan, Shelby. - In: ENDOSCOPY. - ISSN 0013-726X. - 99:6(2024), pp. 867-885. [10.1016/j.gie.2023.12.004]

American Society for Gastrointestinal Endoscopy-European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity

Gianfranco Donatelli;
2024

Abstract

This joint ASGE-ESGE guideline provides an evidence-based summary and recommendations regarding the role of endoscopic bariatric and metabolic therapies (EBMTs) in the management of obesity. The document was developed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework. It evaluates the efficacy and safety of EBMT devices and procedures that currently have CE mark or FDA-clearance/approval, or that had been approved within five years of document development. The guideline suggests the use of EBMTs plus lifestyle modification in patients with a BMI of ≥ 30 kg/m2, or with a BMI of 27.0-29.9 kg/m2 with at least 1 obesity-related comorbidity. Furthermore, it suggests the utilization of intragastric balloons and devices for endoscopic gastric remodeling (EGR) in conjunction with lifestyle modification for this patient population.
2024
American Society for Gastrointestinal Endoscopy-European Society of Gastrointestinal Endoscopy guideline on primary endoscopic bariatric and metabolic therapies for adults with obesity / Jirapinyo, Pichamol; Hadefi, Alia; C Thompson, Christopher; V Patai, Árpád; Pannala, Rahul; K Goelder, Stefan; Kushnir, Vladimir; Barthet, Marc; M Apovian, Caroline; Boskoski, Ivo; G Chapman, Christopher; Davidson, Paul; Donatelli, Gianfranco; Kumbhari, Vivek; Hayee, Bu; Esker, Janelle; Hucl, Tomas; D Pryor, Aurora; Maselli, Roberta; R Schulman, Allison; Pattou, Francois; Zelber-Sagi, Shira; A Bain, Paul; Durieux, Valérie; Triantafyllou, Konstantinos; Thosani, Nirav; Huberty, Vincent; Sullivan, Shelby. - In: ENDOSCOPY. - ISSN 0013-726X. - 99:6(2024), pp. 867-885. [10.1016/j.gie.2023.12.004]
File in questo prodotto:
File Dimensione Formato  
a-2292-2494.pdf

accesso aperto

Licenza: Dominio pubblico
Dimensione 1.03 MB
Formato Adobe PDF
1.03 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/996800
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 14
social impact